BioCentury
ARTICLE | Company News

Achillion management update

October 25, 2010 7:00 AM UTC

Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), New Haven, Conn. Business: Infectious Promoted: Milind Deshpande to president of R&D from EVP of R&D, while remaining CSO; Mary Fenton to SVP from VP, whi...